Reumatismo (Dec 2016)

Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment

  • M. Benucci,
  • A. Damiani,
  • A. Arena,
  • M. Infantino,
  • M. Manfredi,
  • F. Li Gobbi

DOI
https://doi.org/10.4081/reumatismo.2016.911
Journal volume & issue
Vol. 68, no. 3
pp. 163 – 165

Abstract

Read online

We observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg/week. After six months of treatment repeated testing showed no uptake of the discs and vertebral bodies.

Keywords